The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies
Results provide evidence for the validity of a novel, psychometrically robust measure of AB among individuals with depression. Findings indicate that ketamine reliably and rapidly reduces AB, offering insight into a replicable, potential cognitive mechanism involved in its antidepressant action.
Authors
- Neil Jones (ORCID: https://orcid.org/0000-0002-3893-6168)
- Angela Griffo (ORCID: https://orcid.org/0000-0001-9904-0026)
- Rebecca B. Price (ORCID: https://orcid.org/0000-0002-7590-4325)
- Marta Peciña
- Manivel Rengasamy (ORCID: https://orcid.org/0000-0002-1379-743X)
- Ben Grafton (ORCID: https://orcid.org/0000-0002-9920-4278)
- Jay C. Fournier (ORCID: https://orcid.org/0000-0001-8967-1668)
- Iya Cooper
- Rebecca Rohac
- Sharvari Shivanekar (ORCID: https://orcid.org/0000-0002-5924-489X)
- Crystal Spotts
- Kymberly D. Young (ORCID: https://orcid.org/0000-0001-5133-2142)
- Mary L. Woody (ORCID: https://orcid.org/0000-0002-3021-3299)
- Nastasia Mcdonald
Institutions
- Boston University (US)
- University of Pittsburgh (US)
- The University of Western Australia (AU)
- UPMC Health System (US)
- University of Pittsburgh Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Biological Psychiatry
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.biopsych.2024.10.024
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- University of Pittsburgh
- National Institute of Mental Health